Close

Analyst Ratings for Ligand Pharma (LGND)

LGND Rating Summary

LGND Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LGND
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $142.14 (+35.4%) * Over Last 12-Mos
Rating Score: 6.7 / 10   Percentile Rank: 69%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/10/2025 Stifel Annabel Samimy New Coverage Buy
(N/A)
143.00
(N/A)
96.67
(104.97)
8.59% Details
10/1/2024 Oppenheimer
» Updated 2/28/2025
Trevor Allred New Coverage Outperform
(N/A)
142.00
(151.00)
101.35
(104.97)
3.57% Details